ED
MYOK

Exane Derivatives’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Exane Derivatives’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,804
Closed -$246K – 882
2020
Q3 		$246K Buy
1,804
+41
+2% +$4.36K 0.07% 194
2020
Q2 		$170K Sell
1,763
-27
-2% -$2.25K 0.05% 228
2020
Q1 		$83.9K Buy
+1,790
New +$115K 0.02% 303

Exane Derivatives's MYOK Position: Q4 2020 in Review

Exane Derivatives sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,804 shares — an estimated $246K sold.

Exane Derivatives first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $246K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Exane Derivatives reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 1,804 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $246K.
  • Exane Derivatives first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Exane Derivatives's MyoKardia, Inc. Common Stock position peaked at $246K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.